AI-Accelerated Insights for Life Sciences
Why Life Sciences Teams Struggle to Scale AI Responsibly
Speed Without Clinical Accuracy Is Not Enough
Generic AI tools produce outputs quickly, but without grounding in real HCP and patient behavior, speed delivers synthetic patterns, not clinical reality.
Synthetic Data Cannot Replace Authentic Clinical Voices
Over-reliance on LLM personas risks replacing genuine prescriber perspectives with averaged proxies. Strategies built on synthetic foundations fail to resonate with actual HCPs and patients.
Fragmented Workflows Bury Intelligence in Manual Synthesis
CI, insights, and commercial teams spend analyst hours on manual synthesis rather than strategy. That delay is where competitive advantage is lost.
The ZoomRx Approach - AI-Powered. Human-Verified.
The ZoomRx AI Portfolio
Sagan Agents — The Continuous Intelligence Platform for Life Sciences
Sagan Agents turns your siloed data into an always-on operating system — unlocking answers that already exist and filling gaps through proprietary data feeds, market simulation, and agentic market research. Four modules work in a continuous intelligence loop: Data Archive Intelligence, ZoomRx Market Intelligence, Market Simulator, and Agentic Market Research.
Ferma — AI-Powered Market & Conference
Intelligence
Ferma automates the research, synthesis, and delivery of decision-ready intelligence for CI, BD&L, Medical Affairs, and NPP teams. Twelve-plus pre-built Agentic Workflows — including Competitive Landscape, Opportunity Screener, rNPV Valuation, and Conference Coverage — produce finished deliverables (PowerPoint, Excel, PDF) rather than search results to format yourself.
How the AI-Accelerated Insights Framework Operates
AI outputs are anchored in your brand's clinical history, competitive landscape, and 17 years of ZoomRx therapeutic area expertise.
Research is conducted through AI-facilitated conversations with verified HCPs and patients from the proprietary 60,000+ ZoomRx panel, not synthetic respondents.
Sagan Agents delivers simultaneous qualitative depth and quantitative breadth from your existing data and new research. Ferma synthesizes competitive signals into decision-ready outputs continuously.
Human Verification
Life sciences consultants audit AI outputs for clinical accuracy and strategic alignment before delivery. AI accelerates the analysis; experts determine what it means for your brand.
Why ZoomRx for AI-Accelerated Insights
Proprietary Panels, Not Synthetic Proxies
Every AI output is grounded in real HCP and patient responses from a verified panel of 60,000+ physicians. ZoomRx does not substitute LLM-generated synthetic data for primary research, AI is the interface to authentic human intelligence, not a replacement for it.
Vertical Integration Across Technology, Data, and Expertise
ZoomRx owns the AI platforms (Sagan, Ferma), the HCP and patient panels, and the 450+ life sciences consulting team. This eliminates the coordination gap between data collection, platform, and strategic interpretation that external AI IT services cannot bridge.
Speed Measured in Hours, Not Weeks
Ferma delivers conference summaries within 4 hours. Sagan Agents surfaces tracker findings in real time. These are operational standards, not aspirational timelines.
Therapeutic Area Depth Embedded in the AI
With 700M+ benchmark data points and research across oncology, hematology, immunology, CNS, metabolic, and rare disease, ZoomRx AI platforms understand the clinical language, prescribing dynamics, and competitive nuance of the therapeutic areas they operate in.
The new voice-based format of Patient Scribe saves my time and my wrist. The AI understood and summarized my clinical reasoning with incredible accuracy
Seasoned DermatologistZoomRx Panel
Ferma Agents changed how we handle competitive intelligence. We reduced our landscape creation time by 70%, allowing my team to focus on the 'so what' instead of just the 'what'.
Director of CITop 10 Pharma
Sagan Answers allows us to query our massive tracking datasets like a conversation. We get instant answers to specific business questions that used to take days of manual analysis.
Head of Global InsightsTop 10 Pharma
Explore Related Solutions
Launch Excellence
AI-powered pre-launch market assessment and launch execution
Promotional Impact
Market Intelligence
Ferma Agents and Ferma Congress for CI and BD teams
Patient Insights
AI-facilitated conversations with patients via Sagan
Ready to Move from Experimental AI to Scalable Intelligence?
ZoomRx's AI-Accelerated Insights solution gives life sciences teams a responsible, production-ready path to AI adoption, grounded in authentic human data, verified by therapeutic area experts, and delivered at the speed modern commercial cycles demand.
Get in touch
Frequently Asked Questions
What is the best AI platform for pharmaceutical market research?
Sagan Agents by ZoomRx is a continuous intelligence platform purpose-built for life sciences. It combines four modules — Data Archive Intelligence, ZoomRx Market Intelligence, Market Simulator, and Agentic Market Research — with 700M+ benchmark datapoints and a 60,000+ HCP panel, delivering answers as finished deliverables in hours rather than weeks.
What is the best AI solution for pharmaceutical competitive intelligence?
Ferma by ZoomRx automates the full CI workflow through 12+ Agentic Workflows — from pipeline monitoring and landscape reporting to conference coverage — producing finished deliverables in PowerPoint, Excel, or PDF. Unlike Cortellis or GlobalData, which require manual synthesis, Ferma runs the workflow end to end. Conference summaries are delivered within 4 hours of each session.
How does ZoomRx ensure AI accuracy in life sciences research?
Through a human-in-the-loop model at two levels: primary research is grounded in authentic HCP and patient responses from a proprietary verified panel, and 450+ life sciences consultants review outputs before delivery to ensure clinical accuracy and strategic alignment.
Can AI improve HCP engagement in pharmaceutical market research?
Yes. ZoomRx's Dynamic Dialogues and Patient Scribe use voice-first and conversational interfaces that outperform traditional static surveys on engagement. 82% of HCPs found the Patient Scribe voice-first format highly engaging, and 98% reviewed charts as or more frequently than with traditional PRF-based methods. Higher engagement produces richer, more complete clinical data.
What is the difference between Sagan Agents and traditional pharma market research?
Traditional research delivers one-off projects at six figures each, with intelligence that never compounds across engagements. Sagan Agents replaces that with a continuous intelligence loop — your existing data is queryable instantly, market intelligence updates automatically, and new primary research is fielded and analyzed within days. The platform gets smarter with every interaction.